Intuitive Surgical price target raised to $325 from $300 at Truist

Truist analyst Richard Newitter raised the firm’s price target on Intuitive Surgical to $325 from $300 and keeps a Buy rating on the shares after its Q1 earnings beat. The company’s global procedure growth topped estimates while healthy procedure guidance raise should drive a positive stock reaction alongside rising estimates, the analyst tells investors in a research note. Intuitive Surgical’s results and commentary were "very impressive", leaving the firm confident that it can sustain mid-teen revenue and EPS growth per year, Truist added, stating that the company is well-positioned to drive increased penetration into a large and underpenetrated robotic total addressable market.